ENTEROBIOTIX LIMITED
Research and experimental development on biotechnology
ENTEROBIOTIX LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Phoenix House Phoenix Crescent Strathclyde Business Park Bellshill Lanarkshire ML4 3NJ Scotland
Full company profile for ENTEROBIOTIX LIMITED (SC559230), an active life sciences and medical technology company based in Bellshill, Scotland. Incorporated 2 Mar 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2017–2023)
Cash in Bank
£7.36M
Net Assets
-£6.02M
Total Liabilities
£18.22M
Turnover
N/A
Employees
65
Debt Ratio
149%
Financial History
Revenue, profit, EBITDA and key financial figures
2023 Dec Year End | 2022 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 funding rounds
Sign up to view complete fundraising history
Investors (6)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 4 | Jan 2019 | Series A, Seed |
| Investor 1 | Sept 2021 | Series A, Series B |
| Investor 2 | Sept 2021 | Series A |
See all 6 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 17 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Mark Bamforth
British,american
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Morag Bamforth
American
- Significant Influence Or Control
James Roger Mcilroy
Ceased 10 Jan 2020
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 16 Apr 2026 | Capital | Allotment of shares (GBP 9,299.202) on 2026-03-30 | |
| 2 Apr 2026 | Resolution | Resolutions | |
| 2 Apr 2026 | Incorporation | Memorandum Articles | |
| 19 Jan 2026 | Officers | Termination of Felix Andy Awili Olale as director on 2025-12-31 | |
| 22 Oct 2025 | Officers | Termination of David Lawrence as director on 2025-09-30 |
Allotment of shares (GBP 9,299.202) on 2026-03-30
Resolutions
Memorandum Articles
Termination of Felix Andy Awili Olale as director on 2025-12-31
Termination of David Lawrence as director on 2025-09-30
Recent Activity
Latest Activity
Allotment of shares (GBP 9,299.202) on 2026-03-30
2 days ago on 16 Apr 2026
Resolutions
2 weeks ago on 2 Apr 2026
Memorandum Articles
2 weeks ago on 2 Apr 2026
Termination of Felix Andy Awili Olale as director on 2025-12-31
2 months ago on 19 Jan 2026
Termination of David Lawrence as director on 2025-09-30
5 months ago on 22 Oct 2025